MeSH tree: D12.776.377.715.548.114
It is estimated that more than 5 million people worldwide suffer from ulcerative colitis, a chronic inflammation of the colon that often progresses in stages whose causes have not yet been fully investigated. A new international ...
May 19, 2025
0
83
Science and society collaboration is essential for scientific progress, especially in the health and biomedical fields where basic researchers, clinicians and patients are involved, as shown by the initial results of D-BIOMARK. ...
May 16, 2025
0
64
A new study from Emory University has identified a biological connection between inflammation and deficits in motivation in individuals with schizophrenia, offering new hope for treating symptoms that have long been resistant ...
May 16, 2025
0
86
Vaxart Inc., in collaboration with researchers from multiple academic institutions, evaluated the VXA-G1.1-NN vaccine against norovirus infection. Findings show a 30% reduction in infection rates among vaccinated participants ...
A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus. Traditional approaches haven't worked—largely ...
May 15, 2025
0
94
Worldwide, an estimated 40 million people live with HIV. Two-thirds of this group are on the African continent. In 2023, more than 600,000 people died from HIV-related causes and 1.32 million were infected. There is no vaccine ...
May 15, 2025
0
51
University of Oklahoma researchers have discovered that some bacteria in the gut have their own unique "weapon system" to compete against other bacteria for dominance. Importantly, there is promising evidence that this system ...
May 15, 2025
0
46
Some patients with lupus who possess specific antibodies are at a higher risk of thrombotic events such as a blood clot, stroke or heart attack, a new study led by Johns Hopkins Medicine researchers shows. The finding might ...
May 14, 2025
0
23
Most vaccines—and boosters—are injected directly into muscle tissue, usually in the upper arm, to kickstart the body's immune system in the fight against disease. But for respiratory diseases like COVID-19, it can be important ...
May 13, 2025
0
107
A real-world study based on information from an electronic health records–derived database reveals limited benefits of adding bevacizumab to first-line chemotherapy for patients with ovarian cancer, consistent with previous ...
May 12, 2025
0
13
